Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $156.7800 (1.71%) ($156.7800 - $157.8300) on Thu. Dec. 2, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.64% (three month average) | RSI | 45 | Latest Price | $156.7800(1.71%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.4% a day on average for past five trading days. | Weekly Trend | LGND declines -1.6% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(61%) IWO(61%) IWM(59%) IWC(56%) IWN(55%) | Factors Impacting LGND price | LGND will decline at least -1.32% in a week (0% probabilities). VIXM(-28%) UUP(-19%) VXX(-17%) UNG(-5%) TBT(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.32% (StdDev 2.64%) | Hourly BBV | -0.5 () | Intraday Trend | 0% | | | |
|
Resistance Level | $159.49 | 5 Day Moving Average | $157.41(-0.4%) | 10 Day Moving Average | $159.5(-1.71%) | 20 Day Moving Average | $159.49(-1.7%) | To recent high | -5.5% | To recent low | 22.9% | Market Cap | $2.52b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |